Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma, Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04712903
What this trial is testing

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 101
Testing effectiveness (Phase 2)UnknownNCT03781869
What this trial is testing

Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Third Military Medical University 116
Not applicableStudy completedNCT01138358
What this trial is testing

Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease

Who this might be right for
DyspneaLung CancerMetastatic Cancer
King's College Hospital NHS Trust 50
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Testing effectiveness (Phase 2)Ended earlyNCT00726986
What this trial is testing

Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Afshin Dowlati, MD 18
Testing effectiveness (Phase 2)Study completedNCT00053300
What this trial is testing

Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 30
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)Looking for participantsNCT07531095
What this trial is testing

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Amgen 160
Testing effectiveness (Phase 2)Study completedNCT04055792
What this trial is testing

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Who this might be right for
Extensive Disease Small Cell Lung Cancer
Henan Cancer Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01642251
What this trial is testing

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLarge Cell Lung CarcinomaNeuroendocrine Carcinoma+2 more
National Cancer Institute (NCI) 156
Large-scale testing (Phase 3)Active Not RecruitingNCT05224141
What this trial is testing

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

Who this might be right for
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 460
Large-scale testing (Phase 3)WithdrawnNCT01563601
What this trial is testing

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Cephalon
Testing effectiveness (Phase 2)Study completedNCT00887159
What this trial is testing

Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Ended earlyNCT01159327
What this trial is testing

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Who this might be right for
Small Cell Lung Cancer
National Cancer Center, Korea 13
Testing effectiveness (Phase 2)Ended earlyNCT01859741
What this trial is testing

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy

Who this might be right for
Stage IV Small Cell Lung Cancer
OncoMed Pharmaceuticals, Inc. 172
Testing effectiveness (Phase 2)Looking for participantsNCT07339059
What this trial is testing

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Bindu R Potugari 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04745689
What this trial is testing

Study of AZD2811 + Durvalumab in ES-SCLC

Who this might be right for
Small-Cell Lung Cancer
AstraZeneca 31
Testing effectiveness (Phase 2)Ended earlyNCT06939036
What this trial is testing

Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

Who this might be right for
Small Cell Lung Cancer Extensive StageMerkel Cell Carcinoma
Ariceum Therapeutics GmbH 2
Large-scale testing (Phase 3)UnknownNCT04254471
What this trial is testing

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Haihe Biopharma Co., Ltd. 313
Next Page